SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-001981
Filing Date
2022-02-24
Accepted
2022-02-24 16:22:35
Documents
98
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ntla-20211231.htm   iXBRL 10-K 3932721
2 EX-10.16 ntla-ex10_16.htm EX-10.16 404389
3 EX-10.28 ntla-ex10_28.htm EX-10.28 1108748
4 EX-10.29 ntla-ex10_29.htm EX-10.29 1023860
5 EX-21.1 ntla-ex21_1.htm EX-21.1 5868
6 EX-23.1 ntla-ex23_1.htm EX-23.1 6801
7 EX-31.1 ntla-ex31_1.htm EX-31.1 13707
8 EX-31.2 ntla-ex31_2.htm EX-31.2 13461
9 EX-32.1 ntla-ex32_1.htm EX-32.1 11911
10 GRAPHIC img107231886_0.jpg GRAPHIC 538499
11 GRAPHIC img107231886_1.jpg GRAPHIC 499073
12 GRAPHIC img107231886_2.jpg GRAPHIC 135731
13 GRAPHIC img226446965_0.jpg GRAPHIC 37390
14 GRAPHIC img226446965_1.jpg GRAPHIC 37390
15 GRAPHIC img226446965_2.jpg GRAPHIC 135768
16 GRAPHIC img226446965_3.jpg GRAPHIC 99310
17 GRAPHIC img226446965_4.jpg GRAPHIC 74014
18 GRAPHIC img226446965_5.jpg GRAPHIC 493801
19 GRAPHIC img226446965_6.jpg GRAPHIC 37390
  Complete submission text file 0000950170-22-001981.txt   20023967

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ntla-20211231_cal.xml EX-101.CAL 57597
21 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ntla-20211231_pre.xml EX-101.PRE 490052
22 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ntla-20211231.xsd EX-101.SCH 80954
23 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ntla-20211231_def.xml EX-101.DEF 309077
24 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ntla-20211231_lab.xml EX-101.LAB 641617
92 EXTRACTED XBRL INSTANCE DOCUMENT ntla-20211231_htm.xml XML 2561572
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37766 | Film No.: 22671361
SIC: 2835 In Vitro & In Vivo Diagnostic Substances